172 related articles for article (PubMed ID: 12441929)
1. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience.
Vallancien G; Abou El Fettouh H; Cathelineau X; Baumert H; Fromont G; Guillonneau B
J Urol; 2002 Dec; 168(6):2413-7. PubMed ID: 12441929
[TBL] [Abstract][Full Text] [Related]
2. Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results.
Muto G; Bardari F; D'Urso L; Giona C
J Urol; 2004 Jul; 172(1):76-80. PubMed ID: 15201741
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients.
Nieuwenhuijzen JA; Meinhardt W; Horenblas S
J Urol; 2005 Apr; 173(4):1314-7. PubMed ID: 15758788
[TBL] [Abstract][Full Text] [Related]
4. Prostate sparing cystectomy for bladder cancer: 20-year single center experience.
Mertens LS; Meijer RP; de Vries RR; Nieuwenhuijzen JA; van der Poel HG; Bex A; van Rhijn BW; Meinhardt W; Horenblas S
J Urol; 2014 May; 191(5):1250-5. PubMed ID: 24286830
[TBL] [Abstract][Full Text] [Related]
5. [Radical cystectomy with sparing partial prostate for invasive bladder cancer].
Zhou FJ; Qin ZK; Han H; Liu ZW; Wu ZG
Ai Zheng; 2003 Oct; 22(10):1066-9. PubMed ID: 14558952
[TBL] [Abstract][Full Text] [Related]
6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
7. Oncological evaluation of prostate sparing cystectomy: the Montsouris long-term results.
Rozet F; Lesur G; Cathelineau X; Barret E; Smyth G; Soon S; Vallancien G
J Urol; 2008 Jun; 179(6):2170-4; discussion 2174-5. PubMed ID: 18423740
[TBL] [Abstract][Full Text] [Related]
8. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients.
Botto H; Sebe P; Molinie V; Herve JM; Yonneau L; Lebret T
BJU Int; 2004 Nov; 94(7):1021-5. PubMed ID: 15541120
[TBL] [Abstract][Full Text] [Related]
9. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience.
Gou X; Wang M; He WY; Liu CD; Deng YZ; Ren K; Chen Y
Int Urol Nephrol; 2012 Jun; 44(3):787-92. PubMed ID: 22249369
[TBL] [Abstract][Full Text] [Related]
12. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
13. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
14. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?
Thrasher JB; Frazier HA; Robertson JE; Paulson DF
J Urol; 1994 Aug; 152(2 Pt 1):393-6. PubMed ID: 8015078
[TBL] [Abstract][Full Text] [Related]
15. Long-term functional and oncological outcomes of nerve-sparing and prostate capsule-sparing cystectomy: a single-centre experience.
Saad M; Moschini M; Stabile A; Macek P; Lanz C; Prapotnich D; Rozet F; Cathala N; Mombet A; Sanchez-Salas R; Cathelineau X
BJU Int; 2020 Feb; 125(2):253-259. PubMed ID: 31220396
[TBL] [Abstract][Full Text] [Related]
16. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach.
Colombo R; Bertini R; Salonia A; Da Pozzo LF; Montorsi F; Brausi M; Roscigno M; Rigatti P
J Urol; 2001 Jan; 165(1):51-5; discussion 55. PubMed ID: 11125362
[TBL] [Abstract][Full Text] [Related]
17. [Prostate-sparing cystectomy: long-term functional and oncological results in a series of 25 cases].
Saidi A; Nahon O; Daniel L; Lay F; Lechevallier E; Coulange C
Prog Urol; 2004 Apr; 14(2):172-7; discussion 176. PubMed ID: 15217130
[TBL] [Abstract][Full Text] [Related]
18. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
19. The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome.
Jentzmik F; Schrader AJ; de Petriconi R; Hefty R; Mueller J; Doetterl J; Eickhoff A; Schrader M
World J Urol; 2012 Dec; 30(6):733-9. PubMed ID: 22322390
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: updated experience in 34 patients.
Stein JP; Grossfeld GD; Freeman JA; Esrig D; Ginsberg DA; Cote RJ; Skinner EC; Boyd SD; Lieskovsky G; Skinner DG
J Urol; 1997 Aug; 158(2):400-5. PubMed ID: 9224311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
